A Study of Lebrikizumab in Healthy Japanese and Caucasian Volunteers

NCT01423318 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: lebrikizumab
DRUG: placebo

Sponsor

Genentech, Inc.